Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony G Durmowicz

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 7, 2017
Cystic fibrosis radiographic biomarkers - CommentaryAnthony G Durmowicz
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2016
CF end point commentaryAnthony G Durmowicz
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 16, 2016
Cystic fibrosis biomarker - CommentaryAnthony G Durmowicz
Annals of the American Thoracic Society|December 10, 2015
Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary DiseaseStacy J Chin, Anthony G Durmowicz, Badrul A Chowdhury
Chest|January 2, 2013
Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experienceAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
Chest|October 2, 2013
ResponseAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 5, 2006
Elastin protein levels are a vital modifier affecting normal lung development and susceptibility to emphysemaAdrian Shifren, Anthony G Durmowicz, Russell H Knutsen, et al.
Annals of the American Thoracic Society|October 12, 2017
The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical TrialAnthony G Durmowicz, Robert Lim, Hobart Rogers, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 6, 2008
Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structureAdrian Shifren, Anthony G Durmowicz, Russell H Knutsen, et al.
The New England Journal of Medicine|December 16, 2011
The risks and benefits of indacaterol--the FDA's reviewBadrul A Chowdhury, Sally M Seymour, Theresa M Michele, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 7, 2017
Cystic fibrosis radiographic biomarkers - CommentaryAnthony G Durmowicz
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2016
CF end point commentaryAnthony G Durmowicz
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 16, 2016
Cystic fibrosis biomarker - CommentaryAnthony G Durmowicz
Annals of the American Thoracic Society|December 10, 2015
Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary DiseaseStacy J Chin, Anthony G Durmowicz, Badrul A Chowdhury
Chest|January 2, 2013
Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experienceAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
Chest|October 2, 2013
ResponseAnthony G Durmowicz, Kimberly A Witzmann, Curtis J Rosebraugh, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 5, 2006
Elastin protein levels are a vital modifier affecting normal lung development and susceptibility to emphysemaAdrian Shifren, Anthony G Durmowicz, Russell H Knutsen, et al.
Annals of the American Thoracic Society|October 12, 2017
The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical TrialAnthony G Durmowicz, Robert Lim, Hobart Rogers, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 6, 2008
Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structureAdrian Shifren, Anthony G Durmowicz, Russell H Knutsen, et al.
The New England Journal of Medicine|December 16, 2011
The risks and benefits of indacaterol--the FDA's reviewBadrul A Chowdhury, Sally M Seymour, Theresa M Michele, et al.
Pageof 2